Humira (AbbVie Inc.)
Welcome to the PulseAid listing for the Humira drug offered from AbbVie Inc.. This Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Adalimumab |
| SUBSTANCE NAME: | ADALIMUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2002-12-30 |
| END MARKETING DATE: | 0000-00-00 |
Humira HUMAN PRESCRIPTION DRUG Details:
| Item Description | Humira from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/.8mL) |
| START MARKETING DATE: | 2002-12-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-3797_45805ad6-c43a-4b70-7d7c-d476cf5116b9 |
| PRODUCT NDC: | 0074-3797 |
| APPLICATION NUMBER: | BLA125057 |
Other ADALIMUMAB Pharmaceutical Manufacturers / Labelers:
